ACADIA Pharmaceuticals
ACAD
#3764
Rank
$3.70 B
Marketcap
$21.62
Share price
0.09%
Change (1 day)
-4.80%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of March 2026 : $50.79 Million USD

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is $50.79 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$52.18 M0.37%
2024-12-31$51.99 M-9.11%
2023-12-31$57.2 M-7.73%
2022-12-31$62 M-3.77%
2021-12-31$64.43 M30.04%
2020-12-31$49.54 M405.84%
2019-12-31$9.79 M
2018-12-31N/A
2011-12-31$0.03 M-70.91%
2010-12-31$0.11 M-76.24%
2009-12-31$0.46 M-62.2%
2008-12-31$1.22 M-42.6%
2007-12-31$2.13 M-10.15%
2006-12-31$2.37 M33.28%
2005-12-31$1.78 M-29.57%
2004-12-31$2.53 M-48.01%
2003-12-31$4.86 M-24.36%
2002-12-31$6.43 M386.32%
2001-12-31$1.32 M-77.15%
2000-12-31$5.78 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$54.98 B 108,154.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$63.73 B 125,367.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$43.37 B 85,284.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$46.42 B 91,304.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
$10.91 M-78.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA